Meta Information

ID:proton-pump-inhibitors

Name:Proton Pump Inhibitors

Schema Version:1.5

Alternate Names

• PPIs

Active Compound

null

Intervention Type

therapeutic_agent

Delivery

Route:

oral

Scope:

• systemic

Regulatory Status

• us:rx_drug
• us:otc_drug
• eu:rx_drug
• eu:otc_drug

Indication

Focus:

• disease_treatment
• symptom_management

Description:

Treatment of acid-related conditions such as gastroesophageal reflux disease (GERD), peptic ulcers, H. pylori eradication, and Zollinger-Ellison syndrome.

Typical Protocol

• Typically taken once daily, 30-60 minutes before the first meal of the day.
• Treatment duration ranges from 14 days for OTC use to long-term for chronic conditions under medical supervision.

Expected Cost Mean

Low Cost:

10

High Cost:

250

Cost Type:

monthly

Description:

Generic OTC versions are inexpensive; branded prescriptions can be costly but often insurance-covered.

Summary

Proton Pump Inhibitors irreversibly block the H+/K+ ATPase enzyme system (the 'proton pump') in gastric parietal cells. This action profoundly suppresses stomach acid secretion, providing symptomatic relief and allowing for the healing of damaged esophageal and stomach tissue in acid-related gastrointestinal disorders.

Purpose

Reduces stomach acid to treat GERD and heal peptic ulcers.

Card Summary

A class of drugs that powerfully reduces stomach acid production to treat conditions like GERD and ulcers.

Drug Class

null

Drugs In Class

• omeprazole
• esomeprazole
• lansoprazole
• dexlansoprazole
• pantoprazole
• rabeprazole

Impact

Score:

8.5

Justification:

Highly effective for treating indicated acid-related gastrointestinal diseases and symptoms.

Evidence

Grade:

A

Score:

9.5

Justification:

Extensive, high-quality human RCTs and meta-analyses support efficacy for indicated conditions.

Safety

Score:

5.8

Justification:

Long-term use is associated with multiple risks, including nutrient deficiencies and infections.

Flags

• Long-term use is associated with an increased risk of bone fractures (hip, wrist, spine).
• May increase the risk of Clostridioides difficile (C. diff) infection and pneumonia.
• Can cause deficiencies in magnesium, vitamin B12, and iron with chronic use.
• Associated with an increased risk of chronic kidney disease and acute interstitial nephritis.
• Potential for rebound acid hypersecretion upon discontinuation after long-term use.
• May interact with drugs like clopidogrel, methotrexate, and certain antifungals.

Verdict

Highly effective for indicated diseases; long-term use requires medical supervision.

Qualifier

scope: systemic, focused on disease treatment

Created

2026-05-07T01:06:56.198903Z

Ai Model

Gemini 2.5 Pro (High)

Non Healthspan

True